Syngene India- Basing out & risks to consider before getting in

2023年7月6日

Syngene has been a star performer in the F&O space. I personally had this position on and sold off near 750. Now it gave shakeout down to 735 and seems to be setting up again. Risks to consider if looking at the stock

1. Earnings coming up - should be good, but a risk always
   
2. Overall pharma sector looking good & breaking upwards which is positive
   
3. This stock tends to give shakeouts of about 2-3% down (did it once from 730 back to 690 and then from 770 back to 730. So if you get in, size accordingly and dont keep tight stop
   
4. Selling put spreads when it does give a shakeout is probably the very best way to play this stock (until it breaks the 21 EMA - which at some point it will)
   
5. Keep an eye on volumes - every previously shakeout was on lower than average vols
   

Use the F&O as well as cash equity to get the best out of this name - happy trading.

2023年7月25日

注释

Consolidating - waiting for results

2023年7月27日

注释

Amazing results and big pop - buy